Outcomes for girls without HPV vaccination in Japan

The Lancet Oncology

Volumn 17, Issue 7, 2016, Pages 868-869

  Tanaka, Yusuke ^a   Ueda, Yutaka ^a   Egawa Takata, Tomomi ^a   Yagi, Asami ^a   Yoshino, Kiyoshi ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADVERSE OUTCOME; CANCER MORTALITY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE DISPARITY; HEALTH CARE ORGANIZATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION RATE; JAPAN; MOTOR DYSFUNCTION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PAIN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; ADOLESCENT; ADULT; CHILD; FEMALE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; JAPAN; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; YOUNG ADULT;

EID: 84991108714     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(16)00147-9     Document Type: Note

References (9)

1. 1 Morimoto, A, Ueda, Y, Egawa-Takata, T, et al. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination. Int J Clin Oncol 20 (2015), 549–555.
2. 2 Hanley, SJ, Yoshioka, E, Ito, Y, Kishi, R, HPV vaccination crisis in Japan. Lancet, 385, 2015, 2571.
3. 3 Gilmour, S, Kanda, M, Kusumi, E, Tanimoto, T, Kami, M, Shibuya, K, HPV vaccination programme in Japan. Lancet, 382, 2013, 768.
4. 4 Ueda, Y, Enomoto, T, Sekine, M, Egawa-Takata, T, Morimoto, A, Kimura, T, Japan's failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol 212 (2015), 405–406.
5. 5 The International Federation of Gynecology and Obstetrics. FIGO statement on HPV vaccination safety. http://www.figo.org/news/figo-statement-hpv-vaccination-safety-0014668 (accessed Feb 1, 2016).
6. 6 Fujii, T, Declaration to demand the resumption of recommendations for human papillomavirus (HPV) vaccination for cervical cancer prevention. J Obstet Gynaecol Res 41 (2015), 1859–1860.
7. 7 The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/stf/shingi2/0000102584.html (accessed Feb 1, 2016).
8. 8 WHO. Global Advisory Committee on vaccine safety statement on safety of HPV vaccines. http://www.who.int/vaccine_safety/committee/GACVS_HPV_statement_17Dec2015.pdf, Dec 17, 2015 (accessed Feb 1, 2016).
9. 9 Larson, HJ, Wilson, R, Hanley, S, Parys, A, Paterson, P, Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation. Hum Vaccin Immunother 10 (2014), 2543–2550.